Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 168,923 | 187,253 | 168,573 | 178,023 | 167,117 |
| Cost of Goods | 34,306 | 39,886 | 38,864 | 44,262 | 47,416 |
| Gross Profit | 134,617 | 147,367 | 129,709 | 133,761 | 119,701 |
| Operating Expenses | 132,933 | 123,549 | 270,100 | 105,783 | 106,905 |
| Operating Income | 1,990 | 24,704 | -139,527 | 28,240 | 13,212 |
| Interest Expense | 4,580 | 4,680 | 4,689 | 3,884 | 3,316 |
| Other Income | 11,296 | 5,502 | 5,360 | 12,228 | 3,744 |
| Pre-tax Income | 8,706 | 25,526 | -138,856 | 36,584 | 13,640 |
| Income Tax | 3,894 | 9,485 | 4,610 | 17,698 | 4,661 |
| Net Income Continuous | 4,812 | 16,041 | -143,466 | 18,886 | 8,979 |
| Net Income | $4,812 | $16,041 | $-143,466 | $18,886 | $8,979 |
| EPS Basic Total Ops | 0.10 | 0.36 | -3.11 | 0.41 | 0.19 |
| EPS Basic Continuous Ops | 0.10 | 0.35 | -3.11 | 0.41 | 0.19 |
| EPS Diluted Total Ops | 0.10 | 0.38 | -3.11 | 0.39 | 0.19 |
| EPS Diluted Continuous Ops | 0.10 | 0.41 | -3.11 | 0.37 | 0.17 |
| EPS Diluted Before Non-Recurring Items | 0.39 | 0.71 | 0.53 | 0.64 | N/A |
| EBITDA(a) | $22,115 | $39,394 | $-118,411 | $47,889 | $32,343 |